PI 3-kinase p110beta: A new target for antithrombotic therapy

Shaun P Jackson, Simone Marianne Schoenwaelder, Isaac Goncalves, Warwick Scott Nesbitt, Cindy Li-Shen Yap, Christine E Wright, Vijaya B Kenche, Karen Elizabeth Anderson, Sacha M Dopheide, Yuping Yuan, Sharelle Anne Sturgeon, Hishani Prabaharan, Philip E Thompson, Gregg D Smith, Peter R Shepherd, Nathalie Daniele, Suhasini Kulkarni, Belinda Abbott, Dilek Saylik, Catherine JonesLucy Lu, Simon Giuliano, Sascha Claire Hughan, James A Angus, Alan D Robertson, Hatem Hassan Salem

Research output: Contribution to journalArticleResearchpeer-review

465 Citations (Scopus)
Original languageEnglish
Pages (from-to)507 - 514
Number of pages8
JournalNature Medicine
Volume11
Issue number5
DOIs
Publication statusPublished - 2005

Cite this

Jackson, S. P., Schoenwaelder, S. M., Goncalves, I., Nesbitt, W. S., Yap, C. L-S., Wright, C. E., Kenche, V. B., Anderson, K. E., Dopheide, S. M., Yuan, Y., Sturgeon, S. A., Prabaharan, H., Thompson, P. E., Smith, G. D., Shepherd, P. R., Daniele, N., Kulkarni, S., Abbott, B., Saylik, D., ... Salem, H. H. (2005). PI 3-kinase p110beta: A new target for antithrombotic therapy. Nature Medicine, 11(5), 507 - 514. https://doi.org/10.1038/nm1232